All posts by imreal

Stellar Solutions Announces Defense Programs Leadership Transition


Betsy Pimentel, Stellar Solutions

Betsy Pimentel has provided Stellar Solutions with invaluable technical expertise in defense policy, program management and in-depth knowledge of customer and contractor relations. — Celeste Ford, Stellar Solutions’ Founder and Board Chair

Silicon Valley aerospace company Stellar Solutions has announced that longtime Vice President for Defense Programs Betsy Pimentel will transition to a consulting role for the company effective July 1. Pimentel, who was part of the first U.S. Air Force Academy class of women in 1976, has amassed forty years of proven experience in all aspects of space systems planning, acquisition and operations as well as systems engineering and defense program management.

“Betsy has provided Stellar Solutions with invaluable technical expertise in defense policy, program management and in-depth knowledge of customer and contractor relations. We are incredibly grateful for Betsy’s illustrious leadership and presence over the past 17 years,” said Celeste Ford, Stellar Solutions’ Founder and Board Chair.

Succeeding Betsy Pimentel is Janet Grondin, who joined Stellar Solutions as Director of Emerging Space Capabilities in 2018 after supporting Northrop Grumman Corporation as Director for Overhead Persistent Infrared (OPIR) Exploitation Systems as well as Operations Director for MILSATCOM and National Program ground systems. Before that, Grondin served 25 years in the U.S. Air Force in numerous leadership, project management and technical roles, developing significant expertise in command, acquisition, program management, and systems engineering for space and ground systems. These positions included Chief of the Range and Network Division that oversaw the Eastern and Western Ranges; Air Force Satellite Control Network and Standard Space Trainer; Program Manager for the Global Positioning System (GPS) Operational Control Segment; Program Element Monitor for Space Situational Awareness and Special Access; and a Director of Engineering supporting the National Reconnaissance Office.

As VP for Defense Programs, Grondin will assume leadership and oversight of Stellar Solutions’ robust technology, management, and expert solutions for Department of Defense customers related to space and missile systems for national protection and security. These efforts include space superiority, launch enterprise integration, and web services development programs; major programs like GPS and the Space-Based Infrared System; and related capabilities that serve the Air Force in missile warning, weather, precision navigation and timing, and communications. Stellar Solutions has established an exemplary breadth of engagement to ensure continuity of operations across the globe in the event of a threat. The company, which celebrated its 25th anniversary in 2020, is recognizing and leveraging this legacy of success resulting from the decades of commitment by dedicated leaders like Betsy Pimentel, while positioning its team and capabilities for the next 25 years of satisfying customers’ critical needs.

Chief Executive Officer Michael Lencioni remarked, “We are also pleased to further Stellar’s rich history as a woman-owned company by maintaining our comparatively high percentage of women in top leadership positions. There are five points of the Stellar ‘star’: intelligence, defense, civil, commercial, and international. As of today, Stellar’s eight technical Vice Presidents include three women—in addition to Janet, we have Melissa Ferrell as VP for Commercial Programs and Amy Chaput as VP for Civil Programs. Women are responsible for a majority of these key technical lines of business, in addition to Celeste Ford and Betsy Pimentel remaining in vital executive positions—yet another example of our company ‘Leading the Way’.”

Stellar Solutions: Delivering High-impact Performance on Earth and in Space

Founded in 1995 by Celeste Ford with the vision to satisfy critical customer needs while realizing employee dream jobs, Stellar Solutions is a small business that delivers high-impact engineering expertise to government and industry customers across a range of professional and technical disciplines. Named one of the best small and medium workplaces in the U.S. by Fortune Magazine and Great Place to Work® since 2014, Stellar Solutions recently received the Malcolm Baldrige National Quality Award, the nation’s highest honor in performance excellence and sustainability.

Serving the intelligence, defense, civil, and commercial sectors, Stellar Solutions provides rapid-response capabilities related to global surveillance and cyber-security, space exploration, risk management, and technology optimization. These solutions to clients’ critical needs involve satellites in space, sensors on Earth, and intricate technology connections across multiple frontiers. This agile business has forged a competitive advantage by crossing boundaries among vital programs and applying the expertise of its entire seasoned workforce to technical challenges. We offer global reach through international sister companies and programs in the UK and continental Europe, and social responsibility with our foundation and QuakeFinder humanitarian research and development effort.

For more information, visit http://www.stellarsolutions.com.

Share article on social media or email:

Bone Foam Inc. Develops a Simple Solution Can Help Save Lives for COVID-19 Patients


covid-19 patients laying on their stomach

Positioning aid for COVID-19 patients to be positioned prone.

Studies out of Wuhan, China previously demonstrated that lying in the prone position has been associated with improved oxygenation in intubated patients. A more recent study out of New York City has demonstrated that prone positioning in awake, non-intubated patients improved blood oxygenation up to 34% which has reduced the need to intubate many of these patients.

As the number of COVID-19 cases increased throughout the country, ventilators became scarce and ICU availability reached capacity. In response, Bone Foam Inc. partnered with an orthopaedic surgeon out of Lennox Hill Hospital in New York, the epicenter of the pandemic at the time, to develop a low-cost solution to aide patients, pulmonologists, and all ICU intensivists in managing complex positioning challenges.

With elective orthopaedic surgeries delayed and hospital staff being overran due to the influx of COVID-19 patients, the Chief of Orthopaedics at Rothman in New York City, was looking for ways to help. The Orthopaedic Residency program repurposed into “Prone Flippers” at the peak of the outbreak and assisted with management of intubated patients afflicted with pneumonia and ARDS due to COVID-19. Together with Bone Foam Inc., they developed the “Prone Foam – Superior Support Pad” to help with management and positioning of these patients in effort to reduce ventilator-induced lung injuries and mortality rates. The design is ideal for patients on a ventilator or those utilizing high-volume oxygen masks as well as those suffering from ARDS, Cystic Fibrosis, and Obstructive Sleep Apnea. Using “Prone Foam” to position patients can improve pulmonary function, blood oxygenation, and help break up thick mucus in the lungs.

Even those who have been diagnosed with COVID-19 and have not been intubated can benefit from improved blood oxygenation by using the Superior Support Pad and lying in the prone position. Early awake “proning” has been shown in a consecutive series out of New York City to successfully avoid intubation in 64% of hospitalized COVID-19 positive patients.

In recognition of their collaboration, Bone Foam dedicated the Superior Support Pad to the brave and repurposed “Prone Flippers” of the Lennox Hill Orthopaedic Residency program.

About Bone Foam

Bone Foam Inc. is an orthopaedic industry leader in medical grade foam positioners that are utilized in hospitals, clinics, and surgery centers around the world. Bone Foam is focused on discovering and developing innovations in patient positioning that are mutually beneficial to surgeons, medical staff, and patients. During these ambivalent times, Bone Foam has been allocating resources to support the positioning needs of COVID-19 patients.

References

1.    https://www.thoracic.org/about/newsroom/press-releases/journal/2020/wuhan-study-is-first-to-describe-how-body-positioning-can-improve-breathing-in-severe-covid-19-patients-requiring-entilation.php

2.    https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2767575

3.    https://journals.lww.com/jbjsjournal/Documents/P-Final_Rahman.pdf

4.    https://onlinelibrary.wiley.com/doi/full/10.1111/acem.13994

Share article on social media or email:

Medpricer Rebrands as Conductiv™, Unveils Category-Defining Integrated Purchased Services Optimization Suite


News Image

Conductiv™, formerly Medpricer, unveiled its new brand and integrated suite for purchased services cost optimization today with the launch of Conductiv Platform™, Conductiv Services™ and Conductiv Contracts™. The rebrand positions Conductiv, the leading end-to-end third-party services optimization company, to broaden its offerings and expand into new markets.

“Third-party services optimization has emerged as a top target for supply chain and finance executives looking to implement cost-saving initiatives,” said Chris Gormley, CEO of Conductiv. “Third-party services include purchased services as well as IT, construction, clinical, HR, marketing and administrative categories. Conductiv’s proprietary spend database shows that organizations spend 22 to 54 percent of their non-labor expenses on third-party services, representing a crucial, untapped source of margin improvement – especially with Conductiv’s ability to drive savings of 24 percent, on average.”

Conductiv empowers supply chains by integrating its technology and proven category expertise – including analytics driven by artificial intelligence, marketplace insights and express contracting negotiation capabilities – onto one integrated cloud-based platform. Its sourcing automation technologies enable members to engage with their own spend data, determine the competitiveness of their contracts, optimize group purchasing organization (GPO) contracts, unite business stakeholders, create transparency on services spend, and accelerate the speed of identifying and implementing cost savings.

Conductiv’s integrated third-party services optimization suite consists of:

  • Conductiv Platform™, a sophisticated, purpose-built procurement automation platform powered by artificial intelligence and machine learning. Drawing insights from large and comprehensive data sets on supplier quality, pricing and service regions, this predictive analytics engine works to maximize savings and gain end-user engagement while minimizing operational risks.
  • Conductiv Services™, a sourcing service that brings in more than 15 years of proven strategic sourcing results. Conductiv Services offers deep category insight, proven sourcing processes, program development and stakeholder governance delivered to meet an organization’s bespoke needs. Unlike traditional consultants, Conductiv Services are boosted by Conductiv Platform to provide specialized, data-driven insights that enhance savings based on the organization’s opportunity areas.
  • Conductiv Contracts™, a first-of-its-kind GPO that works alongside any primary GPO and accelerates the time for organizations to source, negotiate and implement contracts with third-party service providers. Membership is free and open to all organizations regardless of primary GPO affiliation. Conductiv soft-launched its GPO to its customers in April and launches publicly today with inaugural members that include Hennepin Healthcare, McLaren Health Care and Pandion Optimization Alliance.

“We see Conductiv’s rebrand and new positioning as a gamechanger for Pandion,” said Jeanie Smith, Chief Operating Officer of Pandion Optimization Alliance, which serves 17 hospitals and their related health systems in New York state. “Conductiv’s technology alone will allow our members to have greater visibility and control of a significant spend area of spend. In addition, Conductiv Contracts will enable our healthcare systems to partner with our local purchased service providers to not only improve quality and cost, but also increase jobs, within their communities. We are thrilled to be an inaugural member.”

The capability to source contracts from domestic and diversity businesses has emerged as a driving force post-pandemic, as more organizations seek ways to support local communities and improve regional economies. Conductiv Contracts’ technology-enabled sourcing process ensures that suppliers of local, regional and national presence can now compete equally for business within their respective markets.

“With access to a portfolio of local and regional suppliers, Conductiv Contracts gives us the opportunity to better support our local community and unite stakeholders across our organization in our choice of outsourced services,” said David Bueby, Corporate Vice President of Supply Chain Management of Michigan-based McLaren Health Care. “In addition, with greater transparency on our third-party services spend, we’re able to accelerate the speed of our RFPs and negotiations. We’re excited to be an inaugural member of Conductiv Contracts as we aim to increase transparency into spend data and better assess the competitiveness of our own third-party contracts.”

“Hennepin Healthcare has had a very successful relationship with Medpricer and we are looking forward to continuing and expanding our best practice journey with Conductiv,” explained Luis Valadez, Sr. Director of Supply Chain, of Minneapolis-based Hennepin Healthcare. “As healthcare changes, supply chain is looked at to ensure value and to be at the forefront of driving results. Our continued relationship with Conductiv will ensure we meet these goals. We are excited to be a part of this new offering.”

More than ever, organizations must urgently solve financial gaps with minimal impact to their future operations and local communities. Conductiv’s solutions optimize 22-54% of non-labor operating costs, helping executives solve those financial challenges with immediate impact.

For more information, please visit https://conductiv.com.

About Conductiv

Conductiv™, formerly Medpricer, empowers supply chains to optimize their third-party services. As the only end-to-end third-party lifecycle improvement company, Conductiv™ shares its strategic sourcing expertise and category best practices with multiple industries including healthcare, hospitality, government, real estate, transportation and education. The company has led more than 700 bids for more than 120 organizations, exceeding $4 billion in contracted value. Member projects have generated $800 million of documented savings or an average savings value of 24% to date. To learn how supply chains are transforming their savings strategy, visit https://conductiv.com.

Share article on social media or email:

Health Scholars and CareerCert Team Up to Improve Patient Outcomes Through Virtual Reality Training


Healthcare providers consistently give their all to help others, which is why we believe first responders, clinicians and their patients deserve the best training possible.

Health Scholars, the company recognized for voice-directed VR simulations including advanced cardiovascular life support (ACLS) training for first responders and clinicians announces a partnership with CareerCert which will expand their online training to include VR to help emergency and healthcare departments receive consistent, accessible, experience-based ACLS training that can save lives in their community.

While ACLS certifications last for 2 years, ACLS skills can deteriorate within a matter of months if not constantly practiced and refreshed . According to the American Heart Association, to improve outcomes for cardiac arrest the current “approach to resuscitation training should be replaced or supplemented with a spaced practice” that allows emergency and healthcare providers to receive tailored feedback and technology-enhanced training to refresh critical knowledge and skills.

“Health Scholars’ virtual reality training prevents ACLS skills decay by enabling learners to physically engage in code situations at an appropriate frequency,” says Daniel Katz, an ACLS instructor and anesthesiologist. “It’s realistic, clinically accurate, and can be completed at the convenience of the learner.”

“With average adult survival rates of 26% for in-hospital cardiac arrest and up to 11% for out-of-hospital cardiac arrest, continuous improvement to cardiac arrest response and training is an obligation to patients,” says President of Health Scholars Brian Gillett, MD. “First responders and healthcare providers are on the front lines of patient safety and deserve effective, experience-based training and skills assessments.”

To connect emergency and healthcare departments with this vital training, CareerCert now offers Health Scholars’ ACLS virtual reality training as part of their online training solutions. Emergency and healthcare professionals can easily access a wide range of online training options designed to improve patient outcomes, including virtual reality, interactive mobile learning, virtual instructor-led training, scenario-based education, multimedia online courses, and 3D learning.

“In order to keep up with the rapid acceleration of medical knowledge, first responders and healthcare providers need innovative, comprehensive training that fits their schedules and helps them provide the best care possible,” Scott Jensen, Senior Vice President at CareerCert says. “Virtual reality is one key factor in providing quality training that makes an impact.”

Health Scholars’ CEO Cole Sandau adds, “Healthcare providers consistently give their all to help others, which is why we believe first responders, clinicians and their patients deserve the best training possible. Our partnership with the CareerCert division of Carrus

will help ensure that we can bring effective VR training to a larger number of providers and we could not be more excited to add our ACLS VR training to CareerCert’s program.”

This industry-leading ACLS virtual reality training helps emergency and healthcare departments:

● Save up to 83% on training costs compared to high-fidelity simulation-based training

● Refresh provider knowledge and skill in all of the AHA core rhythms

● Reduce the number of educators/proctors needed to run a successful simulation by 75%

● Provide consistent yet flexible training that providers can easily access 24/7

● Manage and report on provider improvement and clinical readiness

● Build provider communication skills, situational awareness, and critical thinking

● Offer deliberate practice and targeted feedback to improve provider care

About Health Scholars

Our mission is to advance healthcare education through virtualization, making experience-based training scalable, accessible and affordable to both Healthcare and Public Safety providers. Our VR platform provides management, delivery and performance analysis of VR simulation training and we offer AI-enabled VR training scenarios for resuscitation, perioperative, obstetrical, and public emergencies, providing a risk-free environment for repeated deliberate practice. For more information, see http://www.HealthScholars.com. You may also contact Chris Ingwalson at (303) 915.0087, or by email at Chris.Ingwalson@HealthScholars.com.

About CareerCert

CareerCert helps first responders and healthcare providers improve outcomes and protect communities through industry-leading online training. We offer innovative continuing education created by and for medical, fire, and EMS professionals. Our online solutions help emergency departments easily manage, track, create, and report on training in one easy place so they can conveniently access the tools they need to stay compliant and protect their communities.

Share article on social media or email:

COVID-19 return-to-school-and-work technology launched to protect students, employees, customers and nursing home residents


The health of our economy depends on being able to rapidly identify individuals who are high risk or have been exposed to the virus and take action to keep them from infecting others.

Smartlink Health Solutions, a leading provider of proactive health and wellness management solutions, today launched Smartlink SiteClear™, a return-to-school-and-work solution that helps organizations to rapidly identify individuals at risk for COVID-19, isolate them, and mitigate the risk of exposure for others.

Across the country, school districts, businesses and nursing homes are scrambling to safely re-open facilities and maintain business continuity while mitigating liability risk. With the variety of symptoms people experience with COVID-19, temperature checking and simple symptom checkers are not enough.

SiteClear delivers a comprehensive COVID-19 solution that integrates rapidly with a wide variety of existing software systems to help keep students, employees, and residents of long-term care facilities safe while containing costs and avoiding legal liability.

“COVID-19 cases are spiking in dozens of states, and the health of our economy depends on being able to rapidly identify individuals who are high risk or have been exposed to the virus and take action to keep them from infecting others,” said Siu Tong, PhD, CEO and founder of Smartlink Health Solutions. “SiteClear automates the most time-consuming aspects of daily health checks, test ordering, contact tracing, and mitigation for a wide variety of organizations and businesses, without requiring expensive new enterprise software installations.”

SiteClear’s rules-based automation, based on Centers for Disease Control (CDC) guidance and academic research, provides complete activity management and documentation to help organizations to:

Monitor – Track the status of employees, customers, students, and residents

Identify – Rapidly identify those who are at the highest risk for COVID-19 based on the most current scientific research

Protect – Visualize the current status of everyone and make the right decisions faster

Respond – Automatically take action to help prevent the virus from spreading, such as notifications, contact tracing, electronic lab test ordering, and more

Mitigate – Keep detailed documentation on everything the organization is doing to keep people safe

Rapid Integration with Virtually Any Technology

Up and running in a matter of days, SiteClear leverages technology that has been deployed by 500 global companies across multiple industries to link tens of thousands of complex systems. The solution can rapidly integrate with virtually any Human Resource Information System (HRIS), Enterprise Risk Management (ERM) solution, or Electronic Health Record (EHR), as well as digital temperature monitoring, wearable sensor data, and other data sources with central or decentralized databases.

Moreover, with SiteClear’s built-in telehealth features, organizations can schedule and conduct telehealth with ease. Telehealth services can be provided either directly through SiteClear or integrated with an existing telehealth vendor.

Visit smartlinkhealth.com to learn more or email info@smartlinkhealth.com to schedule a pilot.

About Smartlink Health Solutions

Smartlink Health Solutions is an innovator in healthcare IT and is focused on helping organizations solve two of their biggest challenges – the transition from reactive care delivery to proactive care delivery, and the quest for seamless data sharing across the care continuum. With Smartlink, organizations can proactively identify individuals at the highest risk for COVID-19 and automatically take action to help prevent the spread of the virus. Smartlink’s software also enables rapid, affordable integration between healthcare IT and other systems via the user interface, eliminating the need for expensive, IT intensive integration projects. In addition, Smartlink provides a single platform that enables physicians to leverage Medicare’s annual wellness, behavioral health and care management programs as a strategic bridge in the journey from fee-for-service to value-based reimbursement. For more information, visit http://www.SmartlinkHealth.com.

Share article on social media or email:

LabArchives adds LabArchives Inventory to Data Management Suite


Today LabArchives announced the addition of LabArchives Inventory to their online suite of collaborative, secure and intuitive data management tools. This new product supports inventory organization and tracking of laboratory consumables, samples and ordered supplies. LabArchives Inventory also connects with LabArchives Electronic Laboratory Notebook (ELN), which is used by more than 450,000 researchers worldwide. LabArchives Inventory is now available on all of LabArchives cloud sites (US, Australia, UK/EU).

LabArchives Inventory is fully customizable for any lab, in any scientific discipline and in any area of inquiry. Its organizational capabilities save time and money and reinforce data reproducibility. Lab managers and researchers can quickly add custom inventory types and storage locations based on what is used in their lab and where it is stored. It is easy to import & export existing inventories in LabArchives Inventory making the startup process very quick. LabArchives Inventory includes various Barcode and QR code scanning and printing options.

LabArchives Inventory provides lab members with a comprehensive view of materials’ location, usage and supply. The search function makes it easy to find specific items needed for an experiment and to view their usage histories. LabArchives Inventory simplifies communication to reduce order and request duplication, failed experiments due to lack (or expiration) of materials.

In addition to providing lab members with item location and usage data, LabArchives Inventory provides order workflow which tracks requests, approvals, orders and receipts. This real-time order status enables better experiment planning.

LabArchives Inventory also provides administrative oversight. Customizable administrative controls include stock thresholds, expiration date notifications and rules for order requests.

Together, LabArchives Inventory and LabArchives ELN offer a comprehensive and effective data management solution. Every item in LabArchives Inventory has a usage history attached to it which includes information on materials used as well as personnel, location and time/date of use. When linked to relevant documentation within LabArchives ELN, this immutable and valuable data lays a strong foundation for reproducibility. Learn more here.

About LabArchives

LabArchives is a SaaS application provider dedicated to better science. Used in research labs and higher education laboratory courses, LabArchives products are used by more than 450,000 scientists and professors to store, publish, and organize research data and to, schedule, track, and organize laboratory supplies and personnel. More than 450 of the world’s leading research institutions trust LabArchives for research data management, collection and research compliance. For more information, visit https://blog.labarchives.com/, https://www.labarchives.com or see us on Facebook, Twitter and LinkedIn.

Share article on social media or email:

$10 Billion Settlement Reached in Roundup Weed Killer Cancer Litigation


Bayer/Monsanto Roundup $10 Billion Settlement Cory Watson Attorneys

“Non-Hodgkin’s Lymphoma is a devastating disease, and many of our clients continue to suffer the effects of this cancer,” said Andrew Jones, attorney at Cory Watson. “This settlement should help our clients rebuild and move forward in a meaningful way.”

Cory Watson Attorneys, alongside many other plaintiff’s firms, have reached a $10.95 billion settlement with Monsanto on behalf of thousands of plaintiffs who claim that exposure to Roundup, the world’s most popular weed killer, caused their cancer.

Cory Watson has filed multiple lawsuits on behalf of plaintiffs against Monsanto, alleging that exposure to their widely used herbicide Roundup was causing Non-Hodgkin’s Lymphoma in farmers, landscapers, maintenance workers, and homeowners.

“It has been a long journey, but we are pleased to find closure for our clients through this settlement,” said Douglas A. Dellaccio Jr., principal attorney and Complex Litigation Practice Co-Chair at Cory Watson.

For nearly 40 years, farmers around the world used Roundup without knowledge of the dangers posed by its use. Monsanto, the maker of Roundup, has failed to place a warning label on its product informing the consumer that the product contains dangerous agricultural chemicals.

In 2015, the World Health Organization found that glyphosate, the principal “weed killer” component of Roundup, is carcinogenic to humans. Monsanto continues to insist that Roundup is harmless and poses no danger to its users, saying it has no plans to pull the product from the market.

“This $10 billion settlement is big news for anyone who may have been exposed to glysophate’s carcinogenic effects,” said J. Curt Tanner, principal attorney at Cory Watson.

The settlement between Monsanto and plaintiffs is being overseen by court-appointed mediator Kenneth Feinberg, who previously managed compensation funds after September 11 and the explosion of the BP Deepwater Horizon oil rig in the Gulf of Mexico.

“Non-Hodgkin’s Lymphoma is a devastating disease, and many of our clients continue to suffer the effects of this cancer,” said R. Andrew Jones, attorney at Cory Watson. “This settlement should help our clients rebuild and move forward in a meaningful way.”

Monsanto faces thousands of lawsuits in federal and state courts over the herbicide. Three cases have gone to trial, with juries returning verdicts of $289 million, $80 million, and $2 billion against Monsanto.

About Cory Watson Attorneys

Cory Watson Attorneys is a nationally recognized personal injury and environmental tort law firm with offices in Birmingham, Alabama; Memphis, and Nashville, Tennessee. The firm has recovered more than $2.7 billion for clients across the country. Cory Watson attorneys are frequently at the forefront of major class actions and multidistrict litigations involving dangerous pharmaceuticals and product liability, and are often appointed to leadership positions in national cases. Firm practice areas include Personal Injury, Product Liability, Class Action, Asbestos, Business & Commercial Litigation, Dangerous Pharmaceuticals, Defective Medical Devices, and Environmental/Toxic Torts.

Share article on social media or email:

Gary Nemmers Named Chief Executive Officer of Magaya Corporation


“The supply chain industry is currently facing unprecedented challenges – and opportunities,” said Gary Nemmers. “I feel a tremendous sense of both duty and pride as I take on the role of CEO at Magaya during this pivotal period.”

Magaya, the leading provider of end-to-end logistics and supply chain automation software, today announced the appointment of executive board member Gary Nemmers to Chief Executive Officer. Nemmers is a charismatic and visionary leader who has worked with several other private equity-backed software companies prior to Magaya. He joined the Magaya Board of Directors in early 2020 and brings with him more than two decades of supply chain industry experience.

“The supply chain industry is currently facing unprecedented challenges – and opportunities,” said Nemmers. “I feel a tremendous sense of both duty and pride as I take on the role of CEO at Magaya during this pivotal period. All of us at Magaya share an absolute devotion to helping our customers succeed and thrive, now and in the long run.”

“Gary has been a valuable contributor to the Magaya board for the past year, and we are thrilled that he has accepted a broader leadership role in the organization as CEO,” said Michael Pantilione, Principal of LLR and Board Member at Magaya.

Nemmers most recently served as CEO and board member of IQMS Software, where he spearheaded significant EBITDA expansion and doubled the revenue before the company was acquired by Dassault Systèmes in January 2019.

Previously, Nemmers served as COO at HighJump Software, Senior VP at Infor, and was the founder and CEO of DataTrend Information Systems, which provided ERP solutions to the JD Edward and PeopleSoft community. His educational background includes a bachelor’s degree in Behavioral Psychology from Northwestern University and an MBA from Kellogg School of Management.

Share article on social media or email:

The Top 50 Financial Technology CEOs of 2020


The Financial Technology Report is pleased to announce the Top 50 Financial Technology CEOs of 2020. These exceptional executives lead some of the most prominent financial technology companies across the globe and have helped define many of the wide scale advancements the industry has undergone over recent years. They are innovators, strategists, and corporate leaders, who have built important organizations that are driving massive change in the way people spend, save, invest, or otherwise manage their financial lives. Thousands of CEOs were reviewed from which a select set was invited to participate in this year’s nomination process.

The process yielded several hundred nominations, which were closely evaluated – a more detailed review of each candidate based on demonstrated leadership capabilities by researching qualified information sources was performed. A keen focus was placed on technological impact on the financial industry, breadth of organization, number of businesses or consumers reached, career achievements and influence in the field and among peers.

It gives The Financial Technology Report team great pleasure to recognize and celebrate the accomplishments of these deserving CEOs.

Gary Norcross (FIS), Patrick Collison (Stripe), Douglas Cifu (Virtu), Max Levchin (Affirm), Dan Shulman (Paypal), Simon Paris (Finastra), Anthony Noto (SoFi), Noah Kerner (Acorns), Jon Stein (Betterment), Eric Poirier (Addepar), David Zalik (Greensky), Jeffery Yabuki (Fiserv), Jonathan Corr (Ellie Mae), Anne Boden (Starling Bank), Jason Gardner (Marqeta), Michael Hayford (NCR), Rob Frohwein (Kabbage), Brian Armstrong (Coinbase), Brock Blake (Lendio), Paul Taylor (Thought Machine), Adam Hughes (Amount), Sergei Bogatenkov (Admiral Markets Group), Michael Reitblat (Forter), Kelly Rodriques (Forge), Michael Carvin (SmartAsset), Renaud Laplanche (Upgrade), Sallie Krawcheck (Ellevest), Colin Walsh (Varo Money), Sam Graziano (Fundation), Sankaet Pathak (SynapseFI), Michael Cassau (Grover), Eyal Shinar (Fundbox), Tore Steen (CrowdStreet), Dan Holt (BillGO), Peter Maragos (Dash Financial), Mazy Dar (OpenFin), Mike Babineau (Second Measure), Angela Ceresnie (Climb Credit), Doug Ricket (PayJoy), Matt Rodak (Fund That Flip), Patrick Boyaggi (Own Up), Michael Nicastro (Continuity), Cale Johnston (ClickSWITCH), Kumesh Aroomoogan (Accern), Saum Noursalehi (tZero), Noah Breslow (OnDeck), Ryan Williams (Cadre), Guillaume Pousaz (Checkout.com), David Kerr (bonkers.ie), Yoshi Yokokawa (Alpaca Markets).

Congratulations to each of this year’s awardees.

About The Financial Technology Report

The Financial Technology Report is a comprehensive source for market research and insights, business news, investment activity and corporate actions related to the financial technology sector. Based in New York City, the firm is run by a seasoned team of editors, writers and media professionals highly knowledgeable on financial technology and the various companies, executives and investors that make up the sector. http://www.thefinancialtechnologyreport.com.

Share article on social media or email:

InBios Receives FDA Emergency Use Authorization for Second COVID-19 Antibody Test


SCoV-2 Detect IgM ELISA

InBios International Inc., a leading developer of diagnostic tests for emerging infectious diseases, announced today that it received Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) for its SCoV-2 Detect IgM ELISA kit, an in vitro diagnostic test for the qualitative detection of IgM antibodies to SARS-CoV-2, the virus that causes COVID-19, in human serum. This marks the first EUA granted for an ELISA that specifically detects IgM antibodies to SARS-CoV-2 and underscores InBios’ success in developing and bringing to market high-quality ELISA kits for emerging infectious diseases.

Earlier this month, InBios received an FDA EUA for its SCoV-2 Detect IgG ELISA kit. In 2011, InBios was the first to be granted a 510(k) clearance from the FDA for its Dengue IgM ELISA kit and offered the first commercial Zika IgM ELISA under FDA’s EUA in 2016.

“We know there is still much to learn about the virus that causes COVID-19 and the disease itself, and that’s why accurate, high-quality antibody tests are so important,” said Dr. Syamal Raychaudhuri, InBios’ chief scientific officer. “InBios’ expertise in emerging infectious diseases, as well as our prior success in developing and receiving authorization for ELISA tests, has enabled us to move quickly into development of much-needed products for COVID-19. Additionally, we’ve increased production capacity and automated some manufacturing capabilities to meet worldwide demand for COVID-19 diagnostics during this pandemic.”

The specific and reliable detection of human IgM antibodies to SARS-CoV-2 may provide indication of recent infection, offering insight into the spread within communities. In performance studies, InBios’ SCoV-2 Detect IgM ELISA kit demonstrated 92.50% sensitivity and 98.95% specificity. The SCoV-2 Detect IgM ELISA kit, which is available to order immediately, includes all reagents and controls required to run 90 test specimens with results in approximately 2 hours.

InBios’s SCoV-2 Detect IgM ELISA kit is intended for use as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2, the virus that causes COVID-19, which may indicate recent or prior infection. At this time, it is unknown how long antibodies persist following infection and if the presence of antibodies confers protective immunity. Samples should be tested with this kit from individuals within 7-64 days post symptom onset to avoid false negative results. Testing is limited to laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. §263a, to perform high complexity tests.

InBios offers other products for COVID-19, including the Smart Detect SARS-CoV-2 rRT-PCR Kit and the SCoV-2 Detect IgG ELISA kit, both of which received FDA EUAs this year. InBios is also developing the SCoV-2 Detect IgM/IgG Rapid Test.

While the SCoV-2 Detect IgM ELISA kit has not been FDA cleared or approved, it has been authorized for use by the FDA under an EUA, which permits use of certain medical products that may be effective during a public health emergency, which was declared for COVID-19 on Jan. 31, 2020. The test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostic tests for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.

For more information about InBios COVID-19 tests, visit: http://www.inbios.com/covid-19/.

For more information on COVID-19, please visit http://www.cdc.gov or http://www.who.int.

About InBios: InBios International Inc. specializes in the design, development and manufacture of diagnostic assays for emerging infectious diseases and biothreats. Founded in 1996 in Seattle, WA, InBios offers superior quality products which are accurate, easy to use and cost effective. InBios offers an extensive catalog of life science reagents, along with a portfolio of more than 25 diagnostic products, including FDA Emergency Use Authorized COVID-19 tests and FDA-cleared ELISA kits for Zika, dengue, and West Nile and rapid test kits for Chagas and leishmaniasis. InBios is GMP compliant, FDA registered, USDA licensed and ISO 13485:2016 certified. For more information, visit http://www.inbios.com.

Share article on social media or email: